Hutchison China MediTech's IPO

Hutchison China MediTech raised a round of funding on March 17, 2016. Investors include Public.

Hutchison China MediTech is a biopharmaceutical company that operates in the discovery, developments and commercialization of targeted therapies for oncology and immunological diseases.…

Articles about Hutchison China MediTech's IPO: